APA (7th ed.) Citation

Lee, J. Y., Nguyen, B., Mukhopadhyay, A., Han, M., Zhang, J., Gujar, R., . . . Twitty, C. G. (2022, June). Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity. Molecular Therapy: Oncolytics.

Chicago Style (17th ed.) Citation

Lee, Jack Y., et al. "Amplification of the CXCR3/CXCL9 Axis via Intratumoral Electroporation of Plasmid CXCL9 Synergizes with Plasmid IL-12 Therapy to Elicit Robust Anti-tumor Immunity." Molecular Therapy: Oncolytics Jun. 2022.

MLA (9th ed.) Citation

Lee, Jack Y., et al. "Amplification of the CXCR3/CXCL9 Axis via Intratumoral Electroporation of Plasmid CXCL9 Synergizes with Plasmid IL-12 Therapy to Elicit Robust Anti-tumor Immunity." Molecular Therapy: Oncolytics, Jun. 2022.